Hereditary Cancer in Clinical Practice

AuthorsKatarzyna Gliniewicz; Klaudia Stempa; Dominika Wokołorczyk; Wojciech Kluźniak; Milena Kiljańczyk; Helena Rudnicka; Tomasz Huzarski; Jacek Gronwald; Jan Uciński; Tadeusz Dębniak; Marta Grabarczyk; Anna Jakubowska; Marek Szwiec; Marcin Lener; Jan Lubiński; Steven A. Narod; Mohammad R. Akbari; Cezary Cybulski

Affiliations1. International Hereditary Cancer Center, Department of Genetics and Pathology, Pomeranian Medical University in Szczecin, Szczecin, Poland; 2. Department of Clinical Genetics and Pathology, University of Zielona Góra, Zielona Góra, Poland; 3. Independent Laboratory of Molecular Biology and Genetic Diagnostics, Pomeranian Medical University, Szczecin, Poland; 4. Clinics of Oncology, University Hospital in Zielona Góra, Zielona Góra, Poland; 5. Women’s College Hospital, Women’s College Research Institute, University of Toronto, Toronto, Canada; 6. Dalla Lana School of Public Health, University of Toronto, Toronto, Canada

AuthorsAdam Stachowski; Cezary Cybulski; Jacek Gronwald; Tomasz Huzarski; Tadeusz Dębniak; Tomasz Byrski; Steven Narod; Rodney Scott; Jan Lubiński

Affiliations1. Department of Genetics and Pathology, International Hereditary Cancer Center, Pomeranian Medical University, Szczecin, Poland; 2. Oncology and Chemotherapy Clinic, University Clinical Hospital no. 2 of the Pomeranian Medical University in Szczecin, Szczecin, Poland; 3. Women’s College Research Institute, Women’s College Hospital, University of Toronto, Toronto, Canada; 4. Centre for Cancer Detection and Therapy, Hunter Medical Research Institute, School of Biomedical Sciences and Pharmacy, Faculty of Health and Medicine, University of Newcastle, Newcastle, Australia; 5. Division of Molecular Medicine, Pathology North, John Hunter Hospital, New Lambton, Australia

AuthorsTrevor L. Hoffman; Sony Wirio; Vivek Sethumadhavan

Affiliations1. Department of Genetics, Southern California Kaiser Permanente Medical Group, Pasadena, USA; 2. Bernard J. Tyson School of Medicine, Kaiser Permanente, Pasadena, USA; 3. Department of Pathology, Southern California Kaiser Permanente Medical Group, Pasadena, USA

AuthorsKirsten Allan; Linda Cicciarelli; Catherine Beard; Geoffrey J. Lindeman; G. Bruce Mann; Paul A. James; Laura E. Forrest

Affiliations1. Department of Paediatrics, The University of Melbourne, Parkville, Australia; 2. Parkville Familial Cancer Centre, Peter MacCallum Cancer Centre, Melbourne, Australia; 3. Department of Medicine, The University of Melbourne, Parkville, Australia; 4. The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia; 5. Department of Surgery, The University of Melbourne, Parkville, Australia; 6. Sir Peter MacCallum, Department of Oncology, The University of Melbourne, Parkville, Australia

AuthorsEric Jonasch; Yan Song; Jonathan Freimark; Manasi Mohan; James Signorovitch; Murali Sundaram

Affiliations1. The University of Texas MD Anderson Cancer Center, Houston, USA; 2. Analysis Group, Inc., Boston, USA; 3. Merck & Co., Inc., Rahway, USA

AuthorsAntoine Dardenne; Camille Loisel; Anna Pellat; Alexandre Perrier; Julie Metras; Thomas Samaille; Yann Parc; Julie Leclerc; Romain Cohen; Thierry André

Affiliations1. Department of Medical Oncology, Saint-Antoine Hospital, AP-HP , Sorbonne University, Paris, France; 2. Department of Genetics, AP-HP, Pitié-Salpêtrière University Hospital, Sorbonne University, Paris, France; 3. Department of Digestive Surgery, AP-HP, Saint-Antoine Hospital, Sorbonne University, Paris, France; 4. Digestive Oncology Department, Gastroenterology, Digestive Endoscopy, Cochin Hospital, AP-HP Centre, Paris, France; 5. Faculty of Médecine, Paris Cité University, Paris, France; 6. Paris Cité University and Sorbonne Paris Nord University, INSERM, INRAe, Center for Research in Epidemiology and Statistics (CRESS), Hôtel Dieu Hospital, Paris, France; 7. Lille University, CNRS, INSERM, CHU Lille, UMR9020-U1277 - CANTHER - Cancer Heterogeneity Plasticity and Resistance to Therapies, Lille, France; 8. Molecular Oncogenetics Unit, Department of Biochemistry and Molecular Biology, Lille University Hospital, Lille, France; 9. Unité Mixte de Recherche Scientifique 938 and SIRIC CURAMUS, Centre de Recherche Saint-Antoine Hospital, Equipe Instabilité des Microsatellites et Cancer, Equipe Labellisée par la Ligue Nationale Contre le Cancer, Inserm, Paris, France

AuthorsAnja Urbas; Polona Ušaj; Boštjan Šeruga; Mateja Krajc; Simona Hotujec; Vida Stegel; Lorna Zadravec Zaletel

Affiliations1. Faculty of Medicine, University of Ljubljana, Ljubljana, Slovenia; 2. Division of Medical Oncology, Institute of Oncology Ljubljana, Ljubljana, Slovenia; 3. Department of Clinical Cancer Genetics, Institute of Oncology Ljubljana, Ljubljana, Slovenia; 4. Department of Molecular Diagnostics, Institute of Oncology Ljubljana, Ljubljana, Slovenia; 5. Biotechnical Faculty, University of Ljubljana, Ljubljana, Slovenia; 6. Division of Radiotherapy, Institute of Oncology Ljubljana, Ljubljana, Slovenia

AuthorsTanya M. Dwarte; Rozanna Alli; Shweta Srinivasa; Fallon Noon; Sumudu Perera Kimmantudawage; Lisa Gordon; Victoria Beshay; Anthony M. Joshua; Raquel Ruiz Araujo; Chris Jalilian; David M. Thomas; Miriam J. Smith; Ingrid Winship; Mandy L. Ballinger; Minmin Li; Katherine M. Tucker; Eliza K. Courtney

Affiliations1. Hereditary Cancer Centre, Prince of Wales Hospital, Randwick, Australia; 2. Genetic Health Queensland, Brisbane, Australia; 3. Family Cancer Service, Westmead Hospital, Westmead, Australia; 4. Genomic Medicine, Royal Melbourne Hospital, Parkville, Australia; 5. Molecular Pathology, Peter MacCallum Cancer Centre, Melbourne, Australia; 6. The Kinghorn Cancer Centre, St Vincent’s Hospital, Garvan Institute of Medical Research, Darlinghurst, Australia; 7. School of Clinical Medicine, UNSW Medicine and Health, UNSW Sydney, Sydney, Australia; 8. Department of Dermatology, Westmead Hospital, Westmead, Australia; 9. Sydney Medical School, Faculty of Medicine and Health, The University of Sydney, Sydney, Australia; 10. Skin Health Institute, Melbourne, Australia; 11. Monash Health, Melbourne, Australia; 12. Centre for Molecular Oncology, UNSW Sydney, Sydney, Australia; 13. Omico, Sydney, Australia; 14. Division of Evolution, Infection and Genomics, School of Biological Sciences, Faculty of Biology, Medicine and Health, University of Manchester, Manchester Academic Health Science Centre, Manchester, UK; 15. Manchester Centre for Genomic Medicine, St Mary’s Hospital, Central Manchester University Hospitals, NSH Foundation Trust, Manchester Academic Health Science Centre, Manchester, UK; 16. Department of Medicine, University of Melbourne, Parkville, Australia; 17. Children’s Cancer Institute, Lowy Cancer Centre, UNSW Sydney, Sydney, Australia; 18. Kids Cancer Centre, Sydney Children’s Hospital, Randwick, Australia

AuthorsZornitsa Kamburova; Savelina Popovska; Chavdar Tsvetkov

Affiliations1. Department of Medical Genetics, Faculty of Pharmacy, Medical University, Pleven, Bulgaria; 2. Centre of Competence in Personalized Medicine, 3D and Telemedicine, Robotic Assisted and Minimally Invasive Surgery – “Leonardo da Vinci”, Pleven, Bulgaria; 3. Department of General and Clinical Pathology, Faculty of Medicine, Medical University, Pleven, Bulgaria; 4. Department of Midwifery Care, Faculty of Health Care, Medical University, Pleven, Bulgaria

AuthorsYusaku Shimizu; Miho Kitai; Masashi Akada; Michihide Maeda; Eri Yamabe; Reisa Kakubari; Tsuyoshi Hisa; Shoji Kamiura

Affiliations1. Department of Gynecology, Osaka International Cancer Institute, Osaka, Japan; 2. Department of Obstetrics and Gynecology, Ashiya Municipal Hospital, Hyogo, Japan